Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00937014 · ClinicalTrials.gov registry record · NA
Assessment of Growth of Infants Fed a New Formula
A NA study of Infant Nutrition, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 3
- Study locations
NCT00937014 is a NA study of Infant Nutrition that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 180 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT00937014, a NA study of Infant Nutrition, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.
Conditions Studied
Interventions
- OTHER standard infant formula
- OTHER Test formula
Study Locations (3)
Indiana
- Pedia Research, LLC - Newburgh
Kentucky
- Pedia Research, LLC - Owensboro
Maryland
- University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00937014
The ClinicalTrials.gov registry entry for NCT00937014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infant Nutrition appearing as the primary indexed condition, and to 2 interventions - of which standard infant formula is the first listed.
NCT00937014 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Indiana, Kentucky, Maryland.
Frequently Asked Questions
What is clinical trial NCT00937014 about?
NCT00937014 is a clinical study titled "Assessment of Growth of Infants Fed a New Formula". The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.
What is the current status of trial NCT00937014?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2010-02. Estimated completion is 2013-06.
What conditions does trial NCT00937014 study?
This clinical trial studies the following conditions: Infant Nutrition.
What interventions are being tested in trial NCT00937014?
The interventions under investigation include: standard infant formula (OTHER), Test formula (OTHER).
Who is sponsoring clinical trial NCT00937014?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00937014 being conducted?
This trial has 3 study locations across Indiana, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.